Browse All
Displaying 1 - 1 of 1
Author:Thakolwiboon, Smathorn Redenbaugh, Vyanka Chen, Bo Hewitt, Sage Shah, Shailee Lotan, Itay Levy, Michael Forcadela, Mirasol Huda, Saif Pique, Julie Marignier, Romain Boutère, Clémence Audoin, Bertrand Poullin, Pascale Champsas, Dimitrios Choi, David Danesh,
Session Name:S38: NMOSD, MOGAD, Demyelinating, and Other
Topic:Autoimmune Neurology
Program Number:S38.004
Author Institution:Mayo Clinic Health System, La Crosse, WI Mayo Clinic, Rochester, MN John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom VUMC, Nashville, TN Vanderbilt Multiple Sclerosis Center, Nashville, TN Massachusetts General Hospital, Charlestown, MA Massachusetts General Hospital/Harvard Medical School, Boston, MA The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom NHS, Liverpool, United Kingdom Lyon University Hospital, Lyon, France Institue of Neurology, UCL, London, United Kingdom Johns Hopkins University, Baltimore, MD Faculty of Medicine Siriraj Hospital, Bangkok Noi, Thailand Vanderbilt University Medical Center, Nashville, TN Khon Kaen University, Khon Kaen, Thailand Mayo Clinic, Jacksonville, FL John Radcliff Hospital Oxford Univeristy Hospitals Trust, Oxford, United Kingdom Great Ormond Street Hospital, London, United Kingdom Mayo Clinic Dept of Neurology, Rochester, MN
